C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/52 (2006.01) A61K 31/451 (2006.01) A61P 35/00 (2006.01) C07D 211/96 (2006.01)
Patent
CA 2516145
The present invention provides compounds having formula (II) or formula (III) and the pharmaceutically acceptable salts thereof; wherein X, n, and R1-R12 are defined herein. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound represented by formula (II) or (III) and a pharmaceutically acceptable carrier or excipient. The compounds are useful for treating cancer.
L'invention concerne des composés de formule (II) ou de formule (III), ainsi que leurs sels pharmaceutiquement acceptables. X, n et R¿1?-R¿12? sont définis dans la présente. L'invention concerne également une composition pharmaceutique comprenant une quantité efficace sur le plan thérapeutique d'un composé représenté par la formule (II) ou la formule (III) et un support ou un excipient pharmaceutiquement acceptable. Lesdits composés s'utilisent dans le traitement du cancer.
Kim Kyungjin
Liu Emily Aijun
Mischke Steven Gregory
F.hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Substituted piperidines as novel mdm2-p53 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted piperidines as novel mdm2-p53 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperidines as novel mdm2-p53 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1594999